10:10am ET
Health and Healthcare
Are Teva’s Earnings Good Enough?
Prior to the markets opening Thursday, Teva Pharmaceutical reported its most recent financial results.
Companies
/Healthcare
Teva- Pharmaceutical Industries Ltd
$36.62
▼ $0.87 (−2.32%) today
Markets closed · 5:03pm ET
TEVA Coverage
Page 22
8:56am ET
Investing
The Top 10 Corporate Earnings for the Week Ahead
24/7 Wall St. has put together a preview of some of the larger companies reporting quarterly results in the coming week.
4:53pm ET
Health and Healthcare
Is a Generic Nexium Purple Pill for You?
Teva Pharmaceutical announced on Monday that the FDA approved the first generic equivalent to Nexium delayed-release capsules in the United States.
1:05pm ET
Health and Healthcare
Is a Biosimilar (Generic) Top Cancer Drug for You?
A biosimilar application filing from Apotex has been accepted by the Food and Drug Administration for version of Amgen's Neulasta.
8:25am ET
Investing
Top Analyst Upgrades and Downgrades: Citrix, GoPro, HP, Microsoft, Oracle, Teva and More
Friday's top analyst upgrades, downgrades and initiations include Citrix Systems, GoPro, Hewlett-Packard, Microsoft, Oracle and Teva Pharmaceutical.
8:45am ET
Investing
Cowen’s Sell-Off Shopping List Loaded With Stocks With Huge Upside Potential
Cowen asked the analysts which stocks should be on their shopping lists. Here are the six with the biggest upside potential.
8:45am ET
Investing
Top Analyst Upgrades and Downgrades: DuPont, GE, King, Microsoft, Xilinx, McDonald’s and More
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Wednesday, July 23, 2014. They include DuPont, General Electric, King, Microsoft, Xilinx and McDonald's.
10:15am ET
Investing
UBS Lists 6 Stocks With Positive Catalysts Coming Soon
In a recent research report, UBS specifically mentions six companies that it advises investors not to use an option strategy on, as they expect near-term catalysts to drive the stocks higher.
8:20am ET
Investing
Top Analyst Upgrades and Downgrades: Alcoa, Cigna, Intel, Molina, Teva, UnitedHealth and More
These are the top analyst upgrades, downgrades and initiations from Wall Street firms for Friday, June 27, 2014. They include Alcoa, Cigna, Intel, Molina Healthcare, Teva Pharmaceutical and UnitedHealth.
8:45am ET
Health and Healthcare
Why Teva Sees a Sell-the-News Reaction to Decent Earnings
Teva Pharmaceutical is finding a bit of a sell-the-news reaction to its first-quarter earnings report. The company said revenues rose 2% from a year ago and net income rose by 8%.
Jon C. Ogg 9:50am ET
Health and Healthcare
Jefferies Initiates Coverage on Specialty Pharmaceutical Takeover Candidates
The specialty pharmaceutical sector is exploding with news of takeovers, exchanges and possible mergers. Here are some of the top stocks started with a rating of Buy at Jefferies.
8:35am ET
Investing
Top Analyst Upgrades and Downgrades: AMD, ARM, Barrick, Netflix, Teva, Valero and More
These are the top analyst upgrades, downgrades and initiations for Tuesday, April 22, 2014. They include AMD, ARM Holdings, Barrick Gold, Netflix, Teva Pharmaceutical and Valero Energy.
12:50pm ET
Health and Healthcare
Teva’s Latest Victory in Effort to Protect Key Patents
Teva Pharmaceutical shares reached a new multiyear high Monday after the U.S. Supreme Court agreed to hear its appeal to revive a patent on its top-selling multiple-sclerosis drug.
8:15am ET
Investing
Top Analyst Upgrades and Downgrades: Compugen, Juniper Networks, Suncor, Yingli and More
These are the top analyst upgrades, downgrades and initiations seen from Wall Street research firms on March 19, 2014. They include Compugen, Enterprise Products Partners, Juniper Networks, Suncor Energy and Yingli Green…
11:05am ET
Health and Healthcare
Why Teva May Be Back From the Dead
Two analyst upgrades on Friday, a new CEO and a 33% increase in its stock price since November may be confirmation that Teva Pharmaceutical Industries is finally rebounding. Analysts think the stock…
